The portfolio manager of one biotech-focused hedge fund recently invested a total of $60 million in three biotech stocks – and given his strong performance record and ability to beat the wider biotech sector with his picks, it may be worth taking a look at his selections. For the three biotech stocks in question, CLICK HERE.
With the current level of market volatility due to the COVID-19 outbreak, a top-performing portfolio manager is advising against making any big bets right now, stating that “Often these types of viral outbreaks are transitory in nature and affect the markets only temporarily. Yet, this one is quite unique causing issues with both demand and supply.” Still, he does see…
For retirees who want to avoid the sting of high adviser fees, investment newsletters can be one of their best – and low-cost – friends. As today’s article explains, “There are a handful of low-cost newsletters available with decades-long track records that provide independent advice. They are not produced by the fund companies they cover. And they offer guidance through…
It’s “the cornerstone of retirement planning” – yet in a recent study, 92% of the American adults surveyed either demonstrated a lack of understanding of it or couldn’t even define what it was! What is this retirement-planning cornerstone? Fixed-income investing – and one portfolio manager cited in today’s article warns that “The lack of knowledge about fixed-income investing is a…